advertisement
Sarmina JS 1
Showing records 1 to 1 | Display all abstracts from Sarmina JS20506 A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clinical Therapeutics 2007; 29: 1915-1923